Sinotherapeutics Inc.
↗Shanghai, China
Sinotherapeutics is a specialty pharmaceutical company focused on the research, development, and commercialization of complex generic products and innovative formulation products (505(b)(2)). Founded in 2012 by a group of scientists returning from the US, the company leverages advanced drug delivery platforms to overcome technological barriers in formulation, particularly for water-insoluble and sustained-release drugs.
The company operates a high-tech R&D center in the Zhangjiang High-Tech Park in Shanghai and maintains large-scale manufacturing facilities in Haimen, Jiangsu Province. Sinotherapeutics is known for being one of the first Chinese companies to successfully launch high-barrier generic products, such as Posaconazole delayed-release tablets, in the US market. It also provides CRO/CMO services to global pharmaceutical partners.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty Generics & Formulation Innovation
SIZE & FINANCIALS
Employees:201-500
Revenue:$60M-$70M
Founded:2012
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$50M (Pre-IPO estimate)
Investors:GTJA Investment Group, Kangsheng Global, Ruijiang Investment
STOCK
Exchange:SSE
Ticker:688247
Market Cap:$769M
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Complex formulation, Sustained-release, Delayed-release
Active Trials:34
Trial Phases:Phase 1: 12 | Phase 2: 8 | Phase 3: 4
FDA Approvals:5
EMA Approvals:2
CORPORATE STRUCTURE
Subsidiaries:Haimen Pharma
Key Partnerships:Vitruvias Therapeutics (US), Kalbe Farma (Southeast Asia), Lannett Company
COMPETITION
Position:Niche Player
Competitors:Teva Pharmaceuticals, Dr. Reddy's Laboratories, Sun Pharma, Hengrui Medicine
LEADERSHIP
Key Executives:
Jun Ye - Chairman
Jiansheng (Jason) Wan - Founder & CEO
Scientific Founders:Jiansheng Wan, Kun Li, Xiaoxi Sheng
Board Members:Jun Ye, Gu Maojian, Siyu Shen
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Sinotherapeutics Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.